BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1343 related articles for article (PubMed ID: 26281821)

  • 1. Resistance Patterns of Escherichia coli in Women with Uncomplicated Urinary Tract Infection Do Not Correlate with Emergency Department Antibiogram.
    Hines MC; Al-Salamah T; Heil EL; Mallemat H; Witting MD; Johnson JK; Winters ME; Hayes BD
    J Emerg Med; 2015 Dec; 49(6):998-1003. PubMed ID: 26281821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and risk factors for trimethoprim-sulfamethoxazole-resistant Escherichia coli among women with acute uncomplicated urinary tract infection in a developing country.
    Gangcuangco LM; Alejandria M; Henson KE; Alfaraz L; Ata RM; Lopez M; Saniel M
    Int J Infect Dis; 2015 May; 34():55-60. PubMed ID: 25748571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotic resistance in isolates recovered from women with community-acquired urinary tract infections presenting to a tertiary care emergency department.
    Filiatrault L; McKay RM; Patrick DM; Roscoe DL; Quan G; Brubacher J; Collins KM
    CJEM; 2012 Sep; 14(5):295-305. PubMed ID: 22967697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and risk factor analysis of trimethoprim-sulfamethoxazole- and fluoroquinolone-resistant Escherichia coli infection among emergency department patients with pyelonephritis.
    Talan DA; Krishnadasan A; Abrahamian FM; Stamm WE; Moran GJ;
    Clin Infect Dis; 2008 Nov; 47(9):1150-8. PubMed ID: 18808361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of UTI antibiograms stratified by ED patient  disposition.
    Grodin L; Conigliaro A; Lee SY; Rose M; Sinert R
    Am J Emerg Med; 2017 Sep; 35(9):1269-1275. PubMed ID: 28410918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance of Escherichia coli urinary isolates in ED-treated patients from a community hospital.
    Fleming VH; White BP; Southwood R
    Am J Emerg Med; 2014 Aug; 32(8):864-70. PubMed ID: 24877721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk Factors for Trimethoprim and Sulfamethoxazole-Resistant Escherichia Coli in ED Patients with Urinary Tract Infections.
    Wesolek JL; Wu JY; Smalley CM; Wang L; Campbell MJ
    Am J Emerg Med; 2022 Jun; 56():178-182. PubMed ID: 35405469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outpatient antibiogram and predictors of ciprofloxacin and trimethoprim-sulfamethoxazole resistant urinary tract infections.
    Valentine-King M; Zoorob R; Grigoryan L; Trautner B
    Ann Fam Med; 2022 Apr; 20(20 Suppl 1):. PubMed ID: 36944052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial susceptibility of Escherichia coli in uncomplicated cystitis in the emergency department: is the hospital antibiogram an effective treatment guide?
    Smith SC; Bazzoli C; Chung I; Johnson A; Martin DR
    Acad Emerg Med; 2015 Aug; 22(8):998-1000. PubMed ID: 26250654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial resistance in uncomplicated urinary tract infections in 3 California EDs.
    Moffett SE; Frazee BW; Stein JC; Navab B; Maselli J; Takhar SS; Gonzales R
    Am J Emerg Med; 2012 Jul; 30(6):942-9. PubMed ID: 21802879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of antibiotic susceptibility of Escherichia coli in urinary isolates from an emergency department with other institutional susceptibility data.
    Zatorski C; Jordan JA; Cosgrove SE; Zocchi M; May L
    Am J Health Syst Pharm; 2015 Dec; 72(24):2176-80. PubMed ID: 26637517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cranberries vs antibiotics to prevent urinary tract infections: a randomized double-blind noninferiority trial in premenopausal women.
    Beerepoot MA; ter Riet G; Nys S; van der Wal WM; de Borgie CA; de Reijke TM; Prins JM; Koeijers J; Verbon A; Stobberingh E; Geerlings SE
    Arch Intern Med; 2011 Jul; 171(14):1270-8. PubMed ID: 21788542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitrofurantoin: the return of an old friend in the wake of growing resistance.
    Kashanian J; Hakimian P; Blute M; Wong J; Khanna H; Wise G; Shabsigh R
    BJU Int; 2008 Dec; 102(11):1634-7. PubMed ID: 18657135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Escherichia coli antimicrobial susceptibility profile and cumulative antibiogram to guide empirical treatment of uncomplicated urinary tract infections in women in the province of Québec, 2010-15.
    Delisle G; Quach C; Domingo MC; Boudreault AA; Gourdeau M; Bernatchez H; Lavallée C
    J Antimicrob Chemother; 2016 Dec; 71(12):3562-3567. PubMed ID: 27494927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey.
    Arslan H; Azap OK; Ergönül O; Timurkaynak F;
    J Antimicrob Chemother; 2005 Nov; 56(5):914-8. PubMed ID: 16174685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergency Department Urinary Antibiograms Differ by Specific Patient Group.
    Jorgensen S; Zurayk M; Yeung S; Terry J; Dunn M; Nieberg P; Wong-Beringer A
    J Clin Microbiol; 2017 Sep; 55(9):2629-2636. PubMed ID: 28615465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and pretherapy susceptibility of pathogens in patients with complicated urinary tract infection or acute pyelonephritis enrolled in a clinical study in the United States from November 2004 through April 2006.
    Peterson J; Kaul S; Khashab M; Fisher A; Kahn JB
    Clin Ther; 2007 Oct; 29(10):2215-21. PubMed ID: 18042477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First-Line Antimicrobial Resistance Patterns of Escherichia coli in Children With Urinary Tract Infection in Emergency Department and Primary Care Clinics.
    Ahmed MN; Vannoy D; Frederick A; Chang S; Lawler E
    Clin Pediatr (Phila); 2016 Jan; 55(1):19-28. PubMed ID: 26040907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic-Resistant E. coli in Uncomplicated Community-Acquired Urinary Tract Infection.
    Klingeberg A; Noll I; Willrich N; Feig M; Emrich D; Zill E; Krenz-Weinreich A; Kalka-Moll W; Oberdorfer K; Schmiemann G; Eckmanns T
    Dtsch Arztebl Int; 2018 Jul; 115(29-30):494-500. PubMed ID: 30135009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Seven-Day Course of TMP-SMX May Be as Effective as a Seven-Day Course of Ciprofloxacin for the Treatment of Pyelonephritis.
    Fox MT; Melia MT; Same RG; Conley AT; Tamma PD
    Am J Med; 2017 Jul; 130(7):842-845. PubMed ID: 28216442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 68.